Monica Otto

Government, Health and Not for Profit


Latest publications

FERRARA L., OTTO M., Aapro M., Albreht T., Jonsson B., Oberst S., Oliver K., Pisani E., Presti P., Rubio I. T., Terkola R., TARRICONE R. How to improve efficiency in cancer care: Dimensions, methods, and areas of evaluation Journal of Cancer Policy, 2022, vol.34, pp.100355
JOMMI C., ARMENI P., BERTOLANI A., COSTA F., OTTO M. The future of Funds for Innovative Medicines: results from a Delphi Study Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish, 2021, vol.8, pp.22-28
JOMMI C., ARMENI P., COSTA F., BERTOLANI A., OTTO M. Implementation of Value-based Pricing for Medicines Clinical Therapeutics, 2020, vol.42, no. 1, pp.15-24
OTTO M., ARMENI P., JOMMI C. Variations in non-prescription drug consumption and expenditure: Determinants and policy implications Health Policy, 2018, vol.122, no. 6, pp.614-620
OTTO M., Pillarella C., JOMMI C. The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy Frontiers in Pharmacology, 2018, vol.9, no. 1069
ARMENI P., BERTOLANI A., COSTA F., OTTO M., JOMMI C. L’acquisto di farmaci in Italia: l’effetto di approcci selettivi in Rapporto OASI 2018 CERGAS (Eds),Egea, chap. 17, pp.611-648, 2018

Related Articles

Hospital Management during pandemic crisis: Lessons Learn...
Required time 1 hour